| CPC A61K 8/347 (2013.01) [A61K 8/0212 (2013.01); A61K 8/062 (2013.01); A61K 8/14 (2013.01); A61K 8/345 (2013.01); A61K 8/375 (2013.01); A61K 8/498 (2013.01); A61K 8/735 (2013.01); A61K 8/9789 (2017.08); A61K 8/9794 (2017.08); A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 9/127 (2013.01); A61K 9/7007 (2013.01); A61K 31/05 (2013.01); A61K 36/45 (2013.01); A61K 36/738 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/22 (2013.01); A61K 47/36 (2013.01); A61K 47/46 (2013.01); A61P 17/10 (2018.01); A61Q 19/08 (2013.01)] | 24 Claims |
|
1. A topical skin care composition comprising:
(i) from about 0.5 w/w to 3.0% w/w rose oil extract containing plant meristematic stem cells;
(ii) from about 1.0 w/w to 3.0% w/w cannabidiol (CBD), and
(iii) a humectant,
wherein the composition is delivered to skin by a cosmetic vehicle which is a nanosome or a liposome.
|